• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; BIORESORBABLE DRUG ELUTING SCAFFOLD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; BIORESORBABLE DRUG ELUTING SCAFFOLD Back to Search Results
Catalog Number 1012463-12
Device Problem Improper or Incorrect Procedure or Method (2017)
Patient Problems Angina (1710); Myocardial Infarction (1969)
Event Date 08/12/2017
Event Type  Injury  
Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.(b)(4).The scaffold remains in the anatomy.Investigation is not complete.A follow-up report will be filed with all additional relevant information.The absorb device is currently not commercially available in the u.S; however, it is similar to a device sold in the u.S.
 
Event Description
It was reported that on (b)(6) 2017, a 3.0x12mm absorb bioresorbable vascular scaffold (bvs) was successfully implanted in the proximal left anterior descending (lad) coronary artery, 80% stenosed lesion.On (b)(6) 2017, the patient presented with clinical symptoms and heartache.An electrocardiogram was performed and st elevated myocardial infarction (stemi) was diagnosed.Coronary angiography was performed and thrombosis could not be confirmed.Medications were provided as treatment.Reportedly, the patient is now at home.Per physician, the cause for the stemi was interruption of dual anti-platelet therapy (dapt).Additionally, per physician, the event was probably related to the device and index procedure.There was no additional information provided regarding this issue.
 
Manufacturer Narrative
(b)(4).There was no reported device malfunction and the product was not returned as the scaffold remains in the anatomy.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.It should be noted that the bioresorbable vascular scaffold (bvs) system, absorb, instructions for use (ifu), instructs the physician to: note the product use by (expiration) date on the package.Based on the case information and related record review, a conclusive cause for the reported patient effects and the relationship to the product, if any, cannot be determined and the treatment appears to be related to the circumstances of the procedure.There is no indication of a product quality issue with respect to design, manufacture or labeling of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM
Type of Device
BIORESORBABLE DRUG ELUTING SCAFFOLD
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, TEMECULA, CA USA REG# 2024168
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
connie speck
abbott vascular
26531 ynez road
temecula, CA 92591-4628
9519143996
MDR Report Key6870716
MDR Text Key86419059
Report Number2024168-2017-07503
Device Sequence Number1
Product Code PNY
Combination Product (y/n)N
Reporter Country CodeRS
PMA/PMN Number
P150023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial,Followup
Report Date 09/29/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/29/2017
Device Catalogue Number1012463-12
Device Lot Number5100261
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/21/2017
Initial Date FDA Received09/15/2017
Supplement Dates Manufacturer Received09/11/2017
Supplement Dates FDA Received09/29/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/01/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention; Disability;
Patient Age61 YR
Patient Weight72
-
-